{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T04:50:46Z","timestamp":1696308646816},"reference-count":28,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Saudi Medicine"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.5144\/0256-4947.2006.296","type":"journal-article","created":{"date-parts":[[2017,5,16]],"date-time":"2017-05-16T09:46:48Z","timestamp":1494928008000},"page":"296-299","source":"Crossref","is-referenced-by-count":5,"title":["Spontaneous singleton and twin pregnancy in two patients with polycystic ovary syndrome and type 2 diabetes following treatment with metformin combined with rosiglitazone"],"prefix":"10.5144","volume":"26","author":[{"given":"Yared N","family":"Demissie","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek M","family":"Fiad","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Klemm","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Dudley Group of Hospitals NHS Trust, Dudley, West Midlands, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afaf","family":"Twfeeg","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, King Faisal Specialist Hospital &amp; Research Centre, Jeddah, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Al-Amoudi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital &amp; Research Centre, Jeddah"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Meer","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Dudley Group of Hospitals NHS Trust"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarik A","family":"Elhadd","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Faisal Specialist Hospital &amp; Research Centre, Jeddah"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of Infertility and Polycystic Ovarian disease: Endocrinological demographic studies","volume":"1","author":"Hull MG","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016294","article-title":"Role of hyperinsulinemia in the pathogenesis of the Polycystic Ovary Syndrome and its clinical implication","volume":"15","author":"Nestler JE","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"e_1_3_2_4_2","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes and impaired glucose tolerance in polycytic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro RS","year":"1999","journal-title":"J Clin Endocrinol Metabol"},{"issue":"1","key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1210\/jcem-50-1-113","article-title":"Correlation of Hyperandrogenism with hyperinsulinemia in Polycystic Ovary Syndrome","volume":"50","author":"Burghen GA","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"e_1_3_2_6_2","first-page":"1626","article-title":"Troglitazone improves ovulation and hirsutism in the Polycystic Ovary Syndrome; a multicenter, double blind, placebo controlled trial","volume":"86","author":"Azziz R","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.fertnstert.2003.08.024","article-title":"Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome","volume":"81","author":"Belli SH","year":"2004","journal-title":"Fertil Steril"},{"issue":"1","key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1210\/jc.2004-1376","article-title":"Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance","volume":"90","author":"Sepillian V","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0015-0282(01)02843-6","article-title":"Improvement in insulin sensitivity followed by ovulation and pregnancy in a woman with polycystic ovary syndrome who was treated with rosiglitazone","volume":"76","author":"Cataldo NA","year":"2001","journal-title":"Fetil Steril"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2337\/diacare.28.9.2333-a","article-title":"Stockpiling of ovarian follicles and the response to rosiglitazone","volume":"28","author":"Vaughan TB","year":"2005","journal-title":"Diabetes Care"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1365-2265.1989.tb00457.x","article-title":"Polycystic Ovary Syndrome: a changing perspective","volume":"31","author":"Franks S","year":"1989","journal-title":"Clin Endocrinol"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.279.9.669","article-title":"Intensity and amount of physical activity in relation to Insulin sensitivity. The Insulin Resistance Atherosclerosis Study","volume":"279","author":"Mayer-Davis EJ","year":"1998","journal-title":"JAMA"},{"issue":"3","key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0029-7844(97)00296-2","article-title":"Menstrual cyclically after metformin therapy in polycystic ovary syndrome","volume":"90","author":"Valezquez E","year":"1997","journal-title":"Obstet Gynecol"},{"issue":"2","key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1210\/jcem.87.2.8261","article-title":"Ovarian function and metabolic factors in women with oligomenorrhoea treated with metformin in a randomised double-blind placebo controlled trials","volume":"87","author":"Fleming R","year":"2002","journal-title":"J Clin Endocrinol Metabol"},{"issue":"5","key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez EM","year":"1994","journal-title":"Metabolism"},{"issue":"1","key":"e_1_3_2_16_2","first-page":"43","article-title":"The use of metformin to augment the induction of ovulation in obese infertile patients with polycystic ovary syndrome","volume":"6","author":"El-Biely MM","year":"2001","journal-title":"Middle East Fertlity Society Journal"},{"issue":"1","key":"e_1_3_2_17_2","first-page":"139","article-title":"Metformin effects on Clinical features, endocrine and metabolic profiles and insulin sensitivity in Polycystic Ovary Syndrome: a randomised, double blind, placebo controlled trial, followed by open long term clinical evaluation","volume":"85","author":"Moghetti P","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/diab.45.12.1661","article-title":"Thiazolidinediones in the treatment of insulin resistance and Type-2 diabetes","volume":"45","author":"Saltiel AR","year":"1996","journal-title":"Diabetes"},{"issue":"11","key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/humrep\/14.11.2700","article-title":"High ovulatory rates with the use of troglitazone in clomiphene-resistant women with polycystic ovary syndrome","volume":"14","author":"Mitwally MFM","year":"1999","journal-title":"Hum Reprod"},{"issue":"2","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1071-55760200260-5","article-title":"Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosigltazone and clomiphene citrate therapy","volume":"10","author":"Shobkshi A","year":"2004","journal-title":"J Soc Gynecol Investig"},{"issue":"3","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0015-0282(02)04843-4","article-title":"Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome","volume":"79","author":"Ghazzeri G","year":"2003","journal-title":"Fertil Steril"},{"issue":"3","key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/09513590500231627","article-title":"The effects of rosiglitazone and metformin on menstrual cyclicity and hirsutism in polycystic ovary syndrome","volume":"21","author":"Yilmaz M","year":"2005","journal-title":"Gynecol Endocrinol"},{"issue":"11","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/BF03345339","article-title":"The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome","volume":"28","author":"Yilmaz M","year":"2005","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2004.02.127","article-title":"Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity","volume":"82","author":"Baillargeon JP","year":"2004","journal-title":"Fertil Steril"},{"issue":"8","key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/humrep\/deg343","article-title":"Pioglitazone and metformin in obese women with polycystic ovary syndrome not optimally responsive to metformin","volume":"18","author":"Glueck CJ","year":"2003","journal-title":"Hum Reprod"},{"issue":"20","key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"16767","DOI":"10.1074\/jbc.M100040200","article-title":"Thiazolidinediones but not metformin directly inhibit the steroidogenic enzymes P450c17 and 3(-hydroxysteroid dehydrogenase","volume":"276","author":"Arlt W","year":"2001","journal-title":"J Biol Chem"},{"issue":"4","key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0015-0282(02)04925-7","article-title":"Metformin has direct effects on human ovarian steroidogenesis","volume":"79","author":"Mansfield R","year":"2003","journal-title":"Fertil Steril"},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.reprotox.2004.02.014","article-title":"Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide and atorvastatin in a diabetic and hypertensive woman","volume":"18","author":"Yaris F","year":"2004","journal-title":"Reprod Toxicol"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.reprotox.2004.11.003","article-title":"A case of rosiglitazone exposure in the second trimester of pregnancy","volume":"19","author":"Kalyoncu N","year":"2005","journal-title":"Reprod Toxicol"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.annsaudimed.net\/index.php\/vol26\/vol26iss4\/4205.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:46:30Z","timestamp":1559461590000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2006.296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["10.5144\/0256-4947.2006.296"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2006.296","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"value":"0256-4947","type":"print"},{"value":"0975-4466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}